Nippon India Pharma Fund - Direct Plan - Growth Option
Invests only in one industry or theme (like banking, pharma, tech). Highly concentrated — bigger swings. From Nippon India Mutual Fund. It's been running since 2 Jan 2013.
What ₹1 lakh would have become
Based on past returnsThese are calculations from the fund's past prices, not a prediction. Real future returns can and often do differ.
Play with a monthly investment
Slide the amount and switch the duration. Left column uses real past prices. Right column projects forward using this fund's historical rate — a calculation, not a prediction.
Vs 37 other funds in Equity Schemes - Sectoral Fund
Descriptive rankings within the same category and plan. Not a recommendation — one fund beating another historically does not mean it will continue to do so.
Year by year
Calendar-year returns. 5 of last 7 years were positive.
Price over time
How the per-unit price has moved. Tap a range to zoom in.
Bumpiness & worst drops
The value swings roughly 13% up or down in a typical year. Finance-speak calls this volatility.
A lump sum invested at the previous peak would have temporarily lost about this much before recovering. Finance-speak calls this max drawdown.
Similar funds you might want to look at
Same category, same plan, sorted by 3-year return. Not recommendations — just neighbours.
Head-to-head comparisons
Side-by-side comparisons of Nippon India Pharma Fund - Direct Plan - Growth Option against other sector funds.
Technical details (for the pros)
Fund info
- Fund house
- Nippon India Mutual Fund
- Category
- Equity Schemes - Sectoral Fund
- Plan
- Direct
- Option
- Growth
- ISIN (Growth)
- INF204K01I50
- ISIN (Div re-invest)
- —
- Fund code
- 118759
- First price on record
- 2 Jan 2013 · 3,363 daily prices
About Nippon India Pharma Fund - Direct Plan - Growth Option
Nippon India Pharma Fund - Direct Plan - Growth Option is a Equity Schemes - Sectoral Fund offered by Nippon India Mutual Fund under the Direct plan with the Growth option. It has approximately 14 years of NAV track record. The fund falls in the sector category — Invests only in one industry or theme (like banking, pharma, tech). Highly concentrated — bigger swings.
The current NAV of Nippon India Pharma Fund - Direct Plan - Growth Option is ₹647.5641 (as of 1 Sep 2026). Historically, it has delivered 14.06% over the last year, 19.72% CAGR over 3 years, 13.85% CAGR over 5 years. Returns are historical and don't predict future performance.
Over the last three years, the fund's prices have moved with 13.0% annualised volatility — a "high" level of bumpiness; its deepest peak-to-trough fall on record was 24.0%. Being mentally prepared for drawdowns of this size is what separates long-term investors from reactive traders.
Frequently asked
What is the latest NAV of Nippon India Pharma Fund - Direct Plan - Growth Option?+
The latest NAV of Nippon India Pharma Fund - Direct Plan - Growth Option is ₹647.5641 as of 1 Sep 2026, down 0.93% from the previous day. NAV is updated once a business day after the market close.
What are the returns of Nippon India Pharma Fund - Direct Plan - Growth Option?+
Nippon India Pharma Fund - Direct Plan - Growth Option has delivered 1-year return 14.06%, 3-year CAGR 19.72%, 5-year CAGR 13.85%, since-inception CAGR 17.70%. Returns are historical and don't predict future performance — markets move in cycles.
What category does Nippon India Pharma Fund - Direct Plan - Growth Option belong to?+
Nippon India Pharma Fund - Direct Plan - Growth Option is categorised as Equity Schemes - Sectoral Fund. Invests only in one industry or theme (like banking, pharma, tech). Highly concentrated — bigger swings.
How risky is Nippon India Pharma Fund - Direct Plan - Growth Option?+
Based on its 3-year annualised volatility of 13.0%, Nippon India Pharma Fund - Direct Plan - Growth Option sits in the "high" risk bucket. Volatility measures how much prices swing — higher means bigger ups and downs along the way.
Is Nippon India Pharma Fund - Direct Plan - Growth Option a direct plan?+
Nippon India Pharma Fund - Direct Plan - Growth Option is a Direct plan (no distributor commission — lower expense ratio) with the Growth option (all returns compound within the fund, no interim payouts).
How old is Nippon India Pharma Fund - Direct Plan - Growth Option?+
Nippon India Pharma Fund - Direct Plan - Growth Option has NAV history available from 2 Jan 2013 — approximately 14 years of track record and 3,363 daily NAV observations.
Numbers are computed from stored daily prices from mfapi.in/AMFI. This is descriptive analytics, not investment advice. Past performance is not indicative of future returns.